Cord Blood Awareness Month continues throughout July, attempting to educate as many families as possible about the benefits of regenerative therapy provided by banking umbilical cord blood. Canada is in an interesting position this year as it marks the first cord blood awareness month since the launch of the national cord blood program last fall.
One of the goals of the campaign is to improve investments in regenerative therapeutic research in Canada and elsewhere. Many Canadians recognize the importance of these investments, and should heed the results of a study south of the border throughout the awareness campaign.
According to a cord blood survey, Canada’s southern cousins support further investments into cord blood stem cell and regenerative therapy research. Approximately 9 out of 10 respondents agree that more research into cord blood stem cell therapy is in the best interests of American families.
The architect of the study is one of the largest cord blood banks in the US, and believes the results will deafen arguments that Americans are opposed to stem cell therapy. Over half of respondents believe cord blood banking is in the best interests of their own families, and would recommend the option to friends or relatives.
Cord blood stem cells, also known as hematopoietic stem cells (HSCs), are being used in a number of clinical trials across the US and elsewhere to test their validity as a source of therapy. These trials involve using cord blood to improve the lives of patients with cerebral palsy, autism, Type 1 Diabetes, and many others.
Cord blood has been used to help patients with leukaemia, lymphoma, and other blood cancers. Researchers believe the results of new clinical trials will lead to therapies for other genetic conditions or disorders.